GH Research PLC - Ordinary Shares — Cash Flow (NASDAQ:GHRS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -15.28 M-26.2 M-33.34 M-42.28 M-43.55 M — Cash from investing activities -104 K-84.69 M-54.1 M65.14 M46.17 M — Cash from financing activities 286.45 M0-204 K-304 K139.65 M — Free cash flow -15.28 M-26.2 M-33.34 M-42.28 M-43.55 M —

News

Helus Pharma: An Undervalued Psychedelic Platform Approaching A Major Catalyst

AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer

Is AtaiBeckley Stock Worth Buying After Its Stronger Rally in 2026?

AtaiBeckley Reflects a New Push for Rapid-Acting Mental Health Drugs

AtaiBeckley Stock Outlook Depends on Key Pipeline Catalysts in 2026

COMPASS Pathways: A Psychedelics Story (NASDAQ:CMPS)

GH Research: Rapid Onset And Short Action Change The Treatment Paradigm (NASDAQ:GHRS)

These Analysts Revise Their Forecasts On GH Research After Q1 Results - GH Research (NASDAQ:GHRS)

Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit

Fresh Middle East Strains Drag on Stocks

GH Research: WH Decision On Psychedelics To Treat Depression Makes Bull Case (NASDAQ:GHRS)

How Trump Sent Psychedelics-Tied Compass Pathways And Others Flying